105 related articles for article (PubMed ID: 6489441)
21. Glucocorticoids facilitate the retention of acquired immobility during forced swimming.
Veldhuis HD; De Korte CC; De Kloet ER
Eur J Pharmacol; 1985 Sep; 115(2-3):211-7. PubMed ID: 4065208
[TBL] [Abstract][Full Text] [Related]
22. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization.
Kalivas PW; Taylor S; Miller JS
J Pharmacol Exp Ther; 1985 Nov; 235(2):537-43. PubMed ID: 2865357
[TBL] [Abstract][Full Text] [Related]
23. The forced swimming test: effects of glucose administration on the response to food deprivation and adrenalectomy.
Jefferys D; Funder JW
Eur J Pharmacol; 1991 Dec; 205(3):267-9. PubMed ID: 1817963
[TBL] [Abstract][Full Text] [Related]
24. Changes in body temperature and metabolic rate following microinjection of Met-enkephalinamide in the preoptic/anterior hypothalamus of rats.
Stanton TL; Sartin NF; Beckman AL
Regul Pept; 1985 Nov; 12(4):333-43. PubMed ID: 3867098
[TBL] [Abstract][Full Text] [Related]
25. Involvement of endogenous enkephalins in the mouse 'behavioral despair' test.
Natan LB; Chaillet P; Lecomte JM; Marçais H; Uchida G; Costentin J
Eur J Pharmacol; 1984 Jan; 97(3-4):301-4. PubMed ID: 6584312
[TBL] [Abstract][Full Text] [Related]
26. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive beta-endorphin: effects of diurnal variation, adrenalectomy, corticosteroids, and opiate agonists and antagonists.
Lim AT; Funder JW
Neuroendocrinology; 1983; 36(3):225-34. PubMed ID: 6300719
[TBL] [Abstract][Full Text] [Related]
27. Effects of taurine on tolerance to [D-Ala2, Met5]enkephalinamide in rats.
Izumi K; Munekata E; Barbeau A; Nakanishi T; Yoshida M; Yamamoto H; Fukuda T
Eur J Pharmacol; 1982 Aug; 82(1-2):55-63. PubMed ID: 7128679
[TBL] [Abstract][Full Text] [Related]
28. Opiate mechanisms in the central amygdala and gastric stress pathology in rats.
Ray A; Henke PG; Sullivan RM
Brain Res; 1988 Feb; 442(1):195-8. PubMed ID: 2834014
[TBL] [Abstract][Full Text] [Related]
29. Central and peripheral involvement of endogenous opioid peptides in gastric protection in stressed rats.
Scoto GM; Parenti C
Pharmacology; 1996 Jan; 52(1):56-60. PubMed ID: 8966203
[TBL] [Abstract][Full Text] [Related]
30. Microinjections of D-Ala2-Met5-enkephalinamide placed into nucleus accumbens suppress hypothalamically elicited hissing in the cat.
Brutus M; Zuabi S; Siegel A
Exp Neurol; 1989 Apr; 104(1):55-61. PubMed ID: 2924870
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of taurine on wet-dog shakes produced by [D-Ala2,Met5] enkephalinamide with reference to effects on hippocampal epileptic discharges.
Yoshida M; Izumi K; Koja T; Fukuda T; Munekata E; Nakanishi T
Neuropharmacology; 1986 Dec; 25(12):1373-8. PubMed ID: 3561715
[TBL] [Abstract][Full Text] [Related]
32. Naloxone-insensitive modulation of gastric acid output by [D-Met2,Pro5]enkephalinamide in rats.
Till M; Szombath D; Gáti T; Székely JI
Eur J Pharmacol; 1990 Jan; 175(3):355-8. PubMed ID: 2323351
[TBL] [Abstract][Full Text] [Related]
33. Changes of dipeptidyl peptidase (DP IV) activity in the T lymphocytes of rats following administration of ACTH, dexamethasone and opiates.
Korányi L; Walentin S; Hepp J; Endröczi E
Exp Clin Endocrinol; 1989 Apr; 93(1):61-8. PubMed ID: 2544437
[TBL] [Abstract][Full Text] [Related]
34. [D-Ala2, Met5]-enkephalinamide: CNS-mediated inhibition of prostaglandin-stimulated intestinal fluid and ion transport in the rat.
Quito FL; Brown DR
Peptides; 1987; 8(6):1029-33. PubMed ID: 3441442
[TBL] [Abstract][Full Text] [Related]
35. [Met5]enkephalin concentrations in rat pituitary are maintained under opioid inhibition.
George SR; Kertesz M
Eur J Pharmacol; 1987 Aug; 140(1):95-8. PubMed ID: 3622625
[TBL] [Abstract][Full Text] [Related]
36. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats.
Million M; Fioramonti J; Gicquel S; Zajac JM; Bueno L
J Pharmacol Exp Ther; 1993 Apr; 265(1):96-102. PubMed ID: 8474035
[TBL] [Abstract][Full Text] [Related]
37. Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement.
Severson K; Tackett RL
Life Sci; 1998; 62(24):2219-29. PubMed ID: 9627081
[TBL] [Abstract][Full Text] [Related]
38. Naloxone and [Met5]enkephalin effects on retention: attenuation by adrenal denervation.
Zhang SY; McGaugh JL; Juler RG; Introini-Collison IB
Eur J Pharmacol; 1987 Jun; 138(1):37-44. PubMed ID: 3622607
[TBL] [Abstract][Full Text] [Related]
39. D-Ala2-Met5-enkephalinamide impairs the acquisition of ethanol preference without influencing sucrose preference.
Sandi C; Borrell J; Guaza C
Physiol Behav; 1990 Sep; 48(3):435-9. PubMed ID: 2176293
[TBL] [Abstract][Full Text] [Related]
40. Enkephalins induce a centrally mediated rise in blood pressure in rats.
Petty MA; de Jong W
Brain Res; 1983 Feb; 260(2):322-5. PubMed ID: 6299461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
